Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Dr. Hiltke assists in developing and implementing plans and goals for the Office of Cancer Clinical Proteomics Research. She also provides leadership and oversight to the Monoclonal Antibody Characterization program. Previously, Dr. Hiltke served as a senior scientist/project manager in assay development at both Wellstat Diagnostics and BioVeris Corporation, where she developed clinical assays for diagnostic markers.

Education

  • Ph.D., Molecular Biology, University of Buffalo, Buffalo, NY
  • B.S. Biology, Nazareth University, Rochester, NY
  • Reviewed:
Email